User profiles for Evaezi Okpokoro

Dr. Evaezi Okpokoro

International Research Center of Excellence, Institute of Human Virology Nigeria
Verified email at ihvnigeria.org
Cited by 160

[HTML][HTML] Trend and enhanced surveillance of Monkeypox during COVID-19 pandemic in Nigeria

…, E Owhodar, J Oladejo, E Okpokoro… - Journal of public …, 2022 - ncbi.nlm.nih.gov
Monkeypox (MPX) is a viral zoonosis with lesions like smallpox. Though rare in Nigeria,
sporadic outbreaks have been reported in 17 states since September 2017. Unfortunately, the …

[HTML][HTML] Debunking the myths perpetuating low implementation of isoniazid preventive therapy amongst human immunodeficiency virus-infected persons

C Akolo, F Bada, E Okpokoro, O Nwanne… - World journal of …, 2015 - ncbi.nlm.nih.gov
Isoniazid preventive therapy (IPT) is the administration of isoniazid (INH) to people with
latent tuberculosis (TB) infection (LTBI) to prevent progression to active TB disease. Despite …

Multicenter pivotal clinical trial of urine malaria test for rapid diagnosis of Plasmodium falciparum malaria

…, W O'Meara, E Okpokoro… - Journal of clinical …, 2017 - Am Soc Microbiol
The need to expand malaria diagnosis capabilities alongside policy requirements for
mandatory testing before treatment motivates exploration of noninvasive rapid diagnostic tests (…

[HTML][HTML] Primary health care: a necessity in developing countries?

E Okpokoro - Journal of public health in Africa, 2013 - ncbi.nlm.nih.gov
Resource limited countries continue to be plagued with rising prevalence of malaria,
tuberculosis, HIV/AIDS as well as other emerging diseases despite the huge financial support …

Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in …

FO Bada, N Blok, E Okpokoro, S Dutt, C Akolo… - PloS one, 2020 - journals.plos.org
Background Globally, drug resistant tuberculosis (DR-TB) continues to be a public health
threat. Nigeria, which accounts for a significant proportion of the global burden of rifampicin/…

Cost of three models of care for drug-resistant tuberculosis patients in Nigeria

FO Bada, E Okpokoro, N Blok, E Meribole, S Dutt… - BMC Infectious …, 2019 - Springer
Background Nigeria accounts for a significant proportion of the global drug-resistant
tuberculosis (DR-TB) burden, a large proportion of which goes untreated. Different models for …

Effectiveness of one dose of MVA-BN vaccine against mpox infection in males in Ontario, Canada: A target trial emulation

…, A Burchell, S Nasreen, L Friedman, E Okpokoro… - medRxiv, 2023 - medrxiv.org
Background: Limited evidence is available on the real-world effectiveness of modified
vaccinia Ankara-Bavarian Nordic vaccine (MVA-BN) against mpox infection. Methods: We …

[HTML][HTML] Epidemiology and psychosocial assessment of COVID-19 among workers of the Nigeria Centre for Disease Control infected with COVID-19

…, DI Olatunji, E Ofeimun, E Okpokoro… - Journal of Public …, 2023 - ncbi.nlm.nih.gov
Background COVID-19 is a global health crisis. By 2021, Nigeria had 230,000 cases. As the
national public health institute, NCDC leads the COVID-19 response. Due to constant …

[PDF][PDF] Prevalence and Risk Factors for Mycobacterium tuberculosis Infection among Health Workers in HIV Treatment Centers in North Central, Nigeria

E Okpokoro, M Lesosky, C Osa-Afiana… - The American Journal …, 2023 - researchgate.net
Mycobacterium tuberculosis and HIV constitute a public health challenge. Health workers (HWs)
in HIV clinics maybe at greater risk of M. tuberculosis infection, considering the high …

Ecologic correlation between underlying population level morbidities and COVID-19 case fatality rate among countries infected with SARS-CoV-2

E Okpokoro, V Igbinomwanhia, E Jedy-Agba… - medRxiv, 2020 - medrxiv.org
Background The ongoing Coronavirus disease 2019 (COVID-19) pandemic is unprecedented
in scope. High income countries (HIC) seemingly account for the majority of the mortalities …